Fig. 1From: Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapySchematic illustration of the combined application of chemotherapy, immunotherapy, and PD-L1 blockade therapy in tumor-bearing mice. CpG, immunopotentiator; CQ, chloroquine, DC, dendritic cell; HS15, Solutol HS15®; OVA, ovalbumin; PEI-OA, polyethyleneimine-oleic acid polymer; PTX, paclitaxelBack to article page